-
BioMed X Launches Rapid Antiviral Response Platform
contractpharma
May 14, 2020
Aims to develop ultrafast new antiviral drug discovery, development and mass-manufacturing tools for rapid scale-up of new medications.
-
BioMed X Starts New Research Program in Autoimmune Diseases with Merck
b3cnewswire
January 17, 2020
BioMed X?announced today the start of a new joint research group in collaboration with Merck. With this new group, BioMed X and Merck extend their ongoing collaboration to a total of six joint research projects at the BioMed X Innovation Center in Heidelb
-
BioMed X Starts New Schizophrenia Research Program with Boehringer Ingelheim
b3cnewswire
January 16, 2020
BioMed X?announced the start of a new joint research group in collaboration with Boehringer Ingelheim at the BioMed?X Innovation Center in Heidelberg.
-
BioMed X Reaches Milestone in Respiratory Disease Research Collaboration with Boehringer Ingelheim
b3cnewswire
December 04, 2019
BioMed X?announced?the successful completion of their first joint research project with Boehringer Ingelheim in the fields of chronic obstructive pulmonary disease (COPD) ...
-
BioMed X Completes Alzheimer’s Disease Research Project
b3cnewswire
October 29, 2019
BioMed X announced the successful completion of their first research collaboration project with AbbVie in the field of tau-mediated neurodegeneration in Alzheimer’s disease.
-
Velabs Therapeutics to Cooperate with BioMed X in the Field of Immunology
b3cnewswire
January 08, 2019
Velabs Therapeutics, specializing in the fast generation of functional therapeutic antibodies, today announced that it has entered into a collaboration agreement with BioMed X Innovation Center.....
-
BioMed X, Roche Enter Immunology Research Pact
contractpharma
March 13, 2018
BioMed X?has entered a new research collaboration with?F. Hoffmann-La Roche?in the field of immunology